Integra LifeSciences Holdings Corporation Detailed Financials
Full historical quarterly statements
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 418.8M | 391.9M | 434.9M | 402.1M | 415.6M | 382.7M | 442.6M | 380.8M |
| Cost of Goods Sold | 199.0M | 167.7M | 219.6M | 176.0M | 206.3M | 188.2M | 193.6M | 180.6M |
| Gross Profit | 219.7M | 224.2M | 215.4M | 226.1M | 209.3M | 194.4M | 249.1M | 200.2M |
| R&D Expenses | 24.3M | 23.5M | 24.8M | 22.5M | 27.0M | 24.7M | 31.2M | 27.4M |
| Operating Expenses | 200.5M | 184.2M | -340.8M | 185.8M | 722.0M | 209.9M | 213.4M | 208.4M |
| Operating Income | 19.3M | 40.1M | 556.2M | 40.3M | -512.7M | -15.5M | 35.6M | -8.2M |
| Other Income / Gains | -14.5M | -42.5M | -551.9M | -47.1M | -18.3M | -14.5M | -13.1M | -12.2M |
| Net Income | 4.5M | -4.6M | -1.7M | -5.4M | -484.1M | -25.3M | 19.4M | -10.7M |
| EPS (Diluted) | 0.06 | -0.06 | -0.022 | -0.07 | -6.33 | -0.33 | 0.25 | -0.14 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.525 | 0.572 | 0.495 | 0.562 | 0.504 | 0.508 | 0.563 | 0.526 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 172.4M | 178.2M | 169.3M | 169.0M | 179.9M | 181.5M | 178.5M | 177.2M |
| Other Expenses | 3.8M | -17.6M | -534.9M | -5.7M | 515.1M | 3.7M | 3.7M | 3.8M |
| Cost And Expenses | 399.5M | 351.8M | -121.3M | 361.8M | 928.3M | 398.1M | 407.0M | 389.0M |
| Interest Income | 4.3M | 1.0M | 4.4M | 5.0M | 4.7M | 1.8M | 4.9M | 5.0M |
| Interest Expense | 23.0M | 26.8M | 23.7M | 22.7M | 21.0M | 20.2M | 19.0M | 19.4M |
| Depreciation And Amortization | 0 | 38.4M | 38.0M | 38.2M | 37.7M | 37.2M | 37.5M | 36.0M |
| Ebitda | 27.7M | 62.9M | 66.0M | 54.1M | -472.2M | 26.0M | 79.1M | 35.0M |
| Ebitdaratio | 0.066 | 0.16 | 0.152 | 0.134 | -1.136 | 0.068 | 0.179 | 0.092 |
| Operating Income Ratio | 0.046 | 0.102 | 1.279 | 0.10 | -1.234 | -0.04 | 0.08 | -0.021 |
| Income Before Tax | 4.7M | -2.4M | 4.3M | -6.8M | -531.0M | -30.0M | 22.5M | -20.4M |
| Income Before Tax Ratio | 0.011 | -0.006 | 0.01 | -0.017 | -1.278 | -0.078 | 0.051 | -0.053 |
| Income Tax Expense | 262K | 2.2M | 6.0M | -1.4M | -46.9M | -4.7M | 3.1M | -9.7M |
| Net Income Ratio | 0.011 | -0.012 | -0.004 | -0.013 | -1.165 | -0.066 | 0.044 | -0.028 |
| Epsdiluted | 0.06 | -0.06 | -0.022 | -0.07 | -6.33 | -0.33 | 0.25 | -0.14 |
| Weighted Average Shs Out | 78.2M | 77.0M | 76.8M | 76.8M | 76.5M | 76.5M | 77.0M | 76.4M |
| Weighted Average Shs Out Dil | 78.2M | 77.0M | 76.8M | 76.8M | 76.5M | 76.5M | 77.0M | 76.4M |